Alto Neuroscience ANRO
NYSE ANRO
$23.38 -1.03 (-4.22%)
As of: Oct 21, 2026 · 3:59 PM EDT

Alto Neuroscience (ANRO) Other financing activities (2023 - 2026)

Updated

Alto Neuroscience's Other financing activities came in at $190,000 for Q1 2026, up 49.6% from $127,000 a year earlier.

Analysis

Alto Neuroscience (ANRO) Other financing activities (2023 - 2026) Analysis & Trends

For FY2025, Alto Neuroscience's Other financing activities was $127,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Alto Neuroscience 999.68 Mn 177.89 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -190,000.00
Mar 31, 2025 -127,000.00
Dec 31, 2023 -1.24 Mn
Sep 30, 2023 -60,000.00
Jun 30, 2023 60,000.00
Mar 31, 2023 -154,000.00
API Access

Alto Neuroscience Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ANRO&period=max&api_key=YOUR_API_KEY